A research team led by gene editing pioneer David R. Liu, PhD, has published how it has applied the technology to develop a one-time treatment for spinal muscular atrophy (SMA) that showed effectiveness in cell and mouse models.
/PRNewswire/ Researchers at Boston Children s Hospital and Harvard Medical School s Department of Neurobiology have developed a new approach to measure.